CVS Health Corp (NYSE:CVS)’s shares surged more than 15% after the pharmacy chain posted positive financial results for the fourth quarter.
Adjusted earnings per share of $1.19 on revenue of $97.71 billion topped analyst expectations of EPS of $0.91 on revenue of $96.89 billion.
Total revenue was up 4.2% year-over-year, with growth in the Health Care Benefits and Pharmacy & Consumer Wellness segments offsetting a decline in the Health Services segment.
For 2025, the company projected adjusted earnings per share in the range of $5.75 to $6, in line with estimates of $5.90, and free cash flow from operations of approximately $6.5 billion.
“Through the continued dedication of our colleagues, we will be positioned for strong performance in 2025 as we deliver simply better care for consumers while improving outcomes and reducing costs,” CVS Health CEO David Joyner said in a statement.
Shares of CVS Health had added 15.2% at about $63 in the early afternoon on Wednesday.